Paying users zone. Data is hidden behind: .
Get 1-month access to Pfizer Inc. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Adjustments to Financial Statements
Adjustments to Current Assets
Pfizer Inc., adjusted current assets
US$ in millions
Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | ||
---|---|---|---|---|---|---|
As Reported | ||||||
Current assets | ||||||
Adjustments | ||||||
Add: Allowance for doubtful accounts | ||||||
After Adjustment | ||||||
Adjusted current assets |
Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).
Adjustments to Total Assets
Pfizer Inc., adjusted total assets
US$ in millions
Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).
1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »
2 Noncurrent deferred tax assets (included in Noncurrent deferred tax assets and other noncurrent tax assets). See details »
Adjustments to Current Liabilities
Pfizer Inc., adjusted current liabilities
US$ in millions
Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | ||
---|---|---|---|---|---|---|
As Reported | ||||||
Current liabilities | ||||||
Adjustments | ||||||
Less: Current restructuring accruals | ||||||
After Adjustment | ||||||
Adjusted current liabilities |
Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).
Adjustments to Total Liabilities
Pfizer Inc., adjusted total liabilities
US$ in millions
Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Noncurrent deferred tax liabilities. See details »
Adjustments to Stockholders’ Equity
Pfizer Inc., adjusted total Pfizer Inc. shareholders’ equity
US$ in millions
Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).
1 Net deferred tax asset (liability). See details »
Adjustments to Capitalization Table
Pfizer Inc., adjusted capitalization table
US$ in millions
Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).
1 Operating lease liability (before adoption of FASB Topic 842). See details »
2 Operating lease liabilities, short-term (included in Other current liabilities). See details »
3 Operating lease liabilities, long-term (included in Other noncurrent liabilities). See details »
4 Net deferred tax asset (liability). See details »
Adjustments to Reported Income
Pfizer Inc., adjusted net income attributable to Pfizer Inc.
US$ in millions
Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).
1 Deferred income tax expense (benefit). See details »